TYK2 variant exerted highly protective effects on a variety of autoimmune diseases reduced toxicity and the risk of infection, including IBD (UC and CD), multiple sclerosis, ankylosing spondylitis, and psoriasis [17]. Here, TYK2 is linked to psoriasis.